Autoimmune hepatitis in childhood
Giorgina Mieli‐Vergani, Diego Vergani – 10 February 2014 – Watch a video presentation of this article
Kidney damage biomarkers: Novel tools for the diagnostic assessment of acute kidney injury in cirrhosis
Florence Wong, Patrick Murray – 8 February 2014
Restoration of portal flow using a pericholedochal varix in adult living donor liver transplantation for patients with total portosplenomesenteric thrombosis
Deok‐Bog Moon, Sung‐Gyu Lee, Chul‐Soo Ahn, Shin Hwang, Ki‐Hun Kim, Tae‐Yong Ha, Gi‐Won Song, Gil‐Chun Park, Dong‐Hwan Jung, Jung‐Man Namkoong, Hyung‐Woo Park, Yo‐Han Park – 7 February 2014 – In total portosplenomesenteric thrombosis patients, cavoportal hemitransposition (CPHT) is indicated but rarely applicable for adult‐to‐adult (A‐to‐A) living donor liver transplantation (LDLT) because partial liver graft requires splanchno‐portal inflow for liver graft regeneration.
Monitoring and treatment of inactive chronic hepatitis B: Is it cost‐effective?
Zobair Younossi, Linda Henry – 7 February 2014
Liver graft allocation for hepatocellular carcinoma patients: Is a forced ablate‐and‐wait protocol nationally applicable?
Fateh Bazerbachi, Elizabeth Aby, John Lake – 7 February 2014
Advances in interferon‐free hepatitis C therapy: 2014 and beyond
Souvik Sarkar, Joseph K. Lim – 7 February 2014
Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology‐pathology correlation and survival of radiation segmentectomy
Michael Vouche, Ali Habib, Thomas J. Ward, Edward Kim, Laura Kulik, Daniel Ganger, Mary Mulcahy, Talia Baker, Michael Abecassis, Kent T. Sato, Juan‐Carlos Caicedo, Jonathan Fryer, Ryan Hickey, Elias Hohlastos, Robert J. Lewandowski, Riad Salem – 6 February 2014 – Resection and radiofrequency ablation (RFA) are treatment options for hepatocellular carcinoma (HCC) <3 cm; there is interest in expanding the role of ablation to 3‐5 cm. RFA is considered high‐risk when the lesion is in close proximity to critical structures.
Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology‐pathology correlation and survival of radiation segmentectomy
Michael Vouche, Ali Habib, Thomas J. Ward, Edward Kim, Laura Kulik, Daniel Ganger, Mary Mulcahy, Talia Baker, Michael Abecassis, Kent T. Sato, Juan‐Carlos Caicedo, Jonathan Fryer, Ryan Hickey, Elias Hohlastos, Robert J. Lewandowski, Riad Salem – 6 February 2014 – Resection and radiofrequency ablation (RFA) are treatment options for hepatocellular carcinoma (HCC) <3 cm; there is interest in expanding the role of ablation to 3‐5 cm. RFA is considered high‐risk when the lesion is in close proximity to critical structures.
HBV reactivation in immunosuppressed patients: Prevention or containment?
Emmy Ludwig – 6 February 2014